Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Shugan Yiyang capsule** is an oral, prescription traditional Chinese medicine formula manufactured by Guizhou Yibai Pharmaceutical. It contains 15 botanical and zoological crude-drug ingredients and is approved in China for functional erectile dysfunction and mild arteriogenic erectile dysfunction associated with the traditional Chinese medicine patterns of liver-qi stagnation and kidney deficiency, with or without blood stasis. The official product information describes traditional actions of soothing liver constraint, relieving depression, promoting blood circulation, and tonifying the kidney; no defined molecular target or validated target-specific mechanism has been established. ([gzcci.com](https://www.gzcci.com/index/Index/detail.html?cid=119&id=5))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shugan Yiyang capsule.